🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot study uses \[18F\]F AraG PET imaging to evaluate the immunologic...
Status
Recruiting
Location
University of Iowa Hospitals and Clinics
Start Date
2023-11-01
Trial ID
NCT06107374
Treatments Being Tested
To evaluate the potential usefulness of 68Ga-NK224 positron emission tomogr...
Status
Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2023-05-30
Trial ID
NCT06754345
This phase II trial tests how well a combination of three immunotherapy dru...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-11-08
Trial ID
NCT06056895
This study aims to determine the feasibility of non-invasive quantitative P...
Status
Terminated
Location
Yale University PET Center
Start Date
2023-02-21
Trial ID
NCT05408871
Treatments Being Tested
This multicenter retrospective study evaluated the efficacy and safety of s...
Status
Completed
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2022-06-01
Trial ID
NCT06916546
To utilize the \[68Ga\]Ga-THP-PDL1-3 molecular probe to non-invasively dete...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-04-01
Trial ID
NCT06383598
Treatments Being Tested
Primary central nervous system diffuse large B-cell lymphoma (PCNSL-DLBCL) ...
Status
Recruiting
Location
Beijing Tongren Hospital, Capital Medical University
Start Date
2026-04-01
Trial ID
NCT07523737
Treatments Being Tested
Background: Immunotherapy drugs help the body to fight cancer. Scientists ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-05-01
Trial ID
NCT03493945
The aim of this study was to establish and optimize the imaging method of \...
Status
Unknown
Location
Huashan Hospital
Start Date
2023-03-12
Trial ID
NCT06165874
Treatments Being Tested
This phase I trial tests the safety, side effects, best dose, and effective...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2025-05-05
Trial ID
NCT06439836